Follow
Thomas Güttler
Title
Cited by
Cited by
Year
Characterisation of the passive permeability barrier of nuclear pore complexes
D Mohr, S Frey, T Fischer, T Güttler, D Görlich
The EMBO journal 28 (17), 2541-2553, 2009
4072009
The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation
JO Lipton, ED Yuan, LM Boyle, D Ebrahimi-Fakhari, E Kwiatkowski, ...
Cell 161 (5), 1138-1151, 2015
3222015
Crystal structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP
T Monecke, T Güttler, P Neumann, A Dickmanns, D Görlich, R Ficner
Science 324 (5930), 1087-1091, 2009
2972009
NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1
T Güttler, T Madl, P Neumann, D Deichsel, L Corsini, T Monecke, R Ficner, ...
Nature structural & molecular biology 17 (11), 1367-1376, 2010
2822010
Ran‐dependent nuclear export mediators: a structural perspective
T Güttler, D Görlich
The EMBO journal 30 (17), 3457-3474, 2011
2352011
The nuclear proteome of a vertebrate
M Wühr, T Güttler, L Peshkin, GC McAlister, M Sonnett, K Ishihara, ...
Current biology 25 (20), 2663-2671, 2015
1352015
Molecular insights into the interaction of PYM with the Mago–Y14 core of the exon junction complex
F Bono, J Ebert, L Unterholzner, T Güttler, E Izaurralde, E Conti
EMBO reports 5 (3), 304-310, 2004
1342004
Exportin 4 mediates a novel nuclear import pathway for Sox family transcription factors
C Gontan, T Güttler, E Engelen, J Demmers, M Fornerod, FG Grosveld, ...
Journal of cell biology 185 (1), 27-34, 2009
1072009
Ribonucleoprotein-dependent localization of the yeast class V myosin Myo4p
C Kruse, A Jaedicke, J Beaudouin, F Bohl, D Ferring, T Güttler, ...
The Journal of cell biology 159 (6), 971-982, 2002
962002
Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl
O Hantschel, S Wiesner, T Güttler, CD Mackereth, LLR Rix, Z Mikes, ...
Molecular cell 19 (4), 461-473, 2005
952005
Structural analysis of large protein complexes using solvent paramagnetic relaxation enhancements
T Madl, T Güttler, D Görlich, M Sattler
Angewandte Chemie International Edition 50 (17), 3993-3997, 2011
802011
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
T Güttler, M Aksu, A Dickmanns, KM Stegmann, K Gregor, R Rees, ...
The EMBO journal 40 (19), e107985, 2021
792021
eIF1A augments Ago2-mediated Dicer-independent miRNA biogenesis and RNA interference
T Yi, H Arthanari, B Akabayov, H Song, E Papadopoulos, HH Qi, ...
Nature communications 6 (1), 7194, 2015
452015
Recapitulation of selective nuclear import and export with a perfectly repeated 12mer GLFG peptide
SC Ng, T Güttler, D Görlich
Nature Communications 12 (1), 4047, 2021
192021
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
M Aksu, P Kumar, T Güttler, W Taxer, K Gregor, B Mußil, O Rymarenko, ...
Antiviral Research 221, 105778, 2024
22024
Nucleoporin-binding nanobodies that either track or inhibit nuclear pore complex assembly
D Görlich, MS Colom, Z Fu, T Güttler, S Trakhanov, V Srinivasan, ...
bioRxiv, 2023.09. 12.557426, 2023
12023
A checkpoint function for Nup98 in nuclear pore formation suggested by novel inhibitory nanobodies
M Solà Colom, Z Fu, P Gunkel, T Güttler, S Trakhanov, V Srinivasan, ...
The EMBO Journal, 1-35, 2024
2024
Therapeutic and diagnostic vhh antibodies against sars-cov-2 and methods for their enhancement
D Görlich, V Cordes, T Güttler, P Gunkel, R Renate, J Krull, K Gregor, ...
US Patent App. 18/007,224, 2023
2023
Therapeutic and diagnostic vhh antibodies against sars-cov-2 and methods for their enhancement
D Görlich, V Cordes, T Güttler, P Gunkel, R Renate, J Krull, K Gregor, ...
US Patent App. 18/007,236, 2023
2023
Therapeutische Nanobodies gegen SARS-CoV-2
T Güttler, M Dobbelstein, D Görlich
BIOspektrum 28 (1), 39-42, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20